WHAT TO EXPECT IN JANUARY 2021 - COVID-19 VACCINE ROLLOUT: GYANT

COVID-19   VACCINE   ROLLOUT   :

WHAT TO EXPECT IN JANUARY 2021

Presenters:

           JUSTIN GRAHAM, MD MS                                               PAIGE HEAPHY

          CHIEF MEDICAL OFFICER, GYANT                               CHIEF INTEGRATION OFFICER, GYANT

    Dr. Graham is a board-certified infectious disease           A former executive at Henry Mayo Newhall Hospital
   specialist with over 20 years’ experience designing         and Cedars-Sinai Health System, Ms. Heaphy has held
healthcare IT solutions and implementing electronic health   numerous leadership positions with a focus on performance
                         records.                               improvement, patient safety, and data and analytics.

                                                                                                                         2

Boston Medical Center healthcare
 workers celebrating the vaccine
                                   3

4

COVID-19 Vaccine Herd Immunity vs. Others
  Ending the pandemic could require COVID-19 vaccination uptake
                                                                                                                 COVID-19 uptake needed 18+
  between 58-94%, higher than most adult vaccine benchmarks
                                                                                                                   to reach herd immunity

                                                                                                                          58-94%
                                                                                       Elderly 65+: Average
      Adults 18-64: Average vaccination rate of between 35% and 40%                  vaccination rate of ~ 70%

                                                                                       69%             70%

                                                                       51%
                                                        48%
                                       38%

    25%              26%

Pneumococcal       Hep B 19+         Flu 18-49          Flu 18+       Flu 50-64   Pneumococcal 65+    Flu 65+            COVID
                                                                                                                             1 -19

 19-64 at risk                                                                                                           scenarios

            Source: CDC | McKinsey & Company
            https://www.mckinsey.com/industries/healthcare-systems-
            and-services/our-insights/covid-19-vaccine-are-                                                                                   5
            consumers-ready

2021 Outlook

        “If we [vaccinate] efficiently enough over Q2 of 2021, by the end of the
         summer, we may actually have enough herd immunity protecting our
           society that as we get to the end of 2021, we could approach very
        much some degree of normality that is close to where we were before.”

                                 DR. ANTHONY FAUCI

                                                                                   6

Public Perceptions Continue to Evolve

   If a COVID-19 vaccine was determined to be safe by scientists and available for free to
   everyone who wanted it, would you….?

   December 2020                           41%                                         30%                    12%              15%

  September 2020                      34%                                    29%                        14%                20%

                                                                                50%
              Definitely get it               Probably get it                Probably not get it              Definitely not get it

Source: KFF COVID-19 Vaccine Monitor (KFF Health Tracking Poll, Nov.30- Dec. 8,2020) | KFF/The Undefeated                             KFF COVID -19
Survey on Race and Health (conducted Aug.20-Sept. 14,2020) | See topline for full question wording                                    Vaccine Monitor

                                                                                                                                                    7

ARE YOU READY?
                 8

Patients & Providers are
Still Waiting for Answers

Providers:
• State-level rules/plans
• What about systems that are in
  multiple states?
• Will Counties be deploying?
• Which vaccine will we get? Will it be the
  same every time?

                                              9

Patients & Providers are
Still Waiting for Answers

Patients:
• When/how do I qualify?
• How effective is it?
• Is it safe?
• What are the side effects?
• How do I get it?

                               10

What Happens in January 2021?

• Fast deployment/improved direction based
  upon difficulties with first deployment
• State-specific plans are clarified
• More vaccines come into play
• What happens after President-Elect Biden
  is sworn in?
• New super-spreader strain

                                             11

What Happens Next?

• Boosters and Phases 1c, 2, 3,
  etc. requiring patient
  communications and scheduling

• Side effects and severe reactions
  monitoring

• Schedule, vaccinate, monitor --
  repeat

• Resume normal business

                                      12

What Should I Be Planning?

1. Establish an ongoing, flexible
   communications strategy

2. Clearly outline the vaccination     DON’T
   process from start to finish for
   patients                            WAIT!
3. Optimize workforce efficiency and
   vaccination capacity

                                               13

QUESTIONS?

             14

THANK YOU!